Skip to Content

AN 415 (Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual) 8 mg (base) / 2 mg (base))

Pill with imprint AN 415 is Orange, Round and has been identified as Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual) 8 mg (base) / 2 mg (base). It is supplied by Amneal Pharmaceuticals.

Buprenorphine/naloxone is used in the treatment of opiate dependence and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Buprenorphine/naloxone 8 mg (base) / 2 mg (base) is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).

Images for AN 415

Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual)

Imprint
AN 415
Strength
8 mg (base) / 2 mg (base)
Color
Orange
Size
11.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Narcotic analgesic combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
3 - Moderate abuse potential
Labeler / Supplier
Amneal Pharmaceuticals
Inactive Ingredients
acesulfame potassium, citric acid anhydrous, FD&C Yellow No. 6, lactose monohydrate, magnesium stearate, mannitol, povidone, sodium citrate, corn starch

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
65162-0415 Amneal Pharmaceuticals LLC
42291-0175 AvKare, Inc.
00406-1924 Mallinckrodt Inc.

Get help with Imprint Code FAQs.

Related Images for "AN 415"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.